Nigeria, March 24 -- Following Roche Nigeria's reports, the National Agency for Food and Drug Administration and Control validated that a falsified batch of Mabthera 500mg is now in distribution. Following complaints from medical professionals, the damaged batch-N2110A09-was traced to Gombe and Kaduna states.



Widely employed to cure blood malignancies and certain autoimmune disorders is MabThera, a rituximab-based injection. Studies, however, showed that the suspect goods were offered at exceptionally low prices, prompting further investigation.



Among the flaws regulators found in the fake version were incorrect language on the packaging, faulty batch information, and obvious differences in the vial design and sealing. These anom...